Advertisement
Screener

ENTERA BIO LTD. (ENTX) Net Margin

ENTERA BIO LTD. (ENTX) Net Margin

  • 2025-03-31: Net Margin -6111.90%.
  • 2024-12-31: Net Margin -2875.61%.
  • 2024-09-30: Net Margin -7192.86%.
  • 2024-06-30: Net Margin -3763.16%.

Complete source-backed net margin history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Net Margin

DateNet Margin
2025-03-31-6111.90%
2024-12-31-2875.61%
2024-09-30-7192.86%
2024-06-30-3763.16%
2022-12-31-21678.57%
2022-09-30-38337.50%
2022-06-30-7238.64%
2022-03-31-5564.71%
2021-12-31-2484.85%
2021-09-30-2295.71%
2021-06-30-2364.22%
2021-03-31-1462.42%

Annual Net Margin

DateNet Margin
2025-12-31-27235.71%
2024-12-31-5271.27%
2022-12-31-9754.48%
2021-12-31-2134.33%
2020-12-31-3072.88%

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33